|
Synonyms: capromab pendetide | CYT-351 | CYT-356 | Indium In 111 capromab | ProstaScint®
capromab is an approved drug (FDA (1996))
Compound class:
Antibody
Comment: Used as an imaging agent (ProstaScint) by labelling with the radionuclide Indium-111 (using capromab pendetide, where the pendetide is the chelating agent for the radiolabel).
|
| No information available. |
Summary of Clinical Use  |
| Used in diagnostic imaging of metastatic prostate cancer in newly diagnosed, high risk patients [1-2]. |
| Mechanism Of Action and Pharmacodynamic Effects |
| This antibody is designed to bind to FOLH1 (prostate-specific membrane antigen, which can be found in the M28: Aminopeptidase Y enzyme family in this database) on the surface of prostate cells. |
